Paul-Lukas Hoffschmidt

Alpha Sophia Helps Medtech Businesses Avoid Overpaying for Healthcare Commercial Intelligence

Alpha Sophia Founder and CEO Paul-Lukas Hoffschmidt explains how the company's software diverges from competitors in healthcare commercial intelligence, by focusing on smaller medtech innovators.

By Stephanie Baum

BioPharma

BioLabs Pegasus Park Cultivates Life Science Ecosystem

Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.